Roche releases recalled eye implant in US
Genentech said it has resumed sales of its Susvimo eye implant in the United States following the end of a voluntary recall, and the device will become available to patients in the coming weeks. The implant was approved by the US health regulator in 2021 to treat a chronic condition that causes blurred vision.
POPULAR POSTS
IEA warns ‘electricity era’ will come after fossil fuels peak
October 17, 2024
Easter Island fights global plastic waste vortex
October 17, 2024
Egypt opens more galleries at its antiquities museum
October 17, 2024
LIVE STREAM